Imrab^® + Potomavac^TM

Rabies Vaccine

Neorickettsia risticii Bacterin

• Equine POTOMAVAC^TM + IMRAB^® contains inactivated rabies virus combined with an inactivated suspension of Neorickettsia risticii

• Recommended for the vaccination of healthy horses against rabies virus and potomac horse fever

• Safety and efficacy of the vaccine has been demonstrated in controlled tests and through field evaluation

Shake well before use. For primary vaccination, aseptically inject 1mL (1 dose) intramuscularly (IM) into healthy horses 3 months of age or older.

For Neorickettsia risticii, revaccinate with a second 1mL dose intramuscularly 3 or 4 weeks later using this product or Potomavac^TM.

Revaccinate annually with a single 1 mL dose of Imrab^®+Potomavac^TM.

What to expect brochure

Why vaccinate brochure

Precautions

• Store at 2-7 ̊C (35-45 °F)

• Do not freeze

• Do not mix with other products

• Use entire contents when first opened

• Do not vaccinate within 21 days before slaughter

• This product has not been tested in pregnant mares

• In case of human exposure contact a physician

In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results.

For veterinary use only.